Randomised trial of coronary intervention with antibody against IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators - Topol, EJ; Califf, RM; Weismann, HF; Ellis, SG; Tchen, JE; Worley, S; Ivanhoe, R; George, BS; Fintel, D; Weston, M (Lancet, 1994)
et al.